Pharmaceutical industry leaders claim ‘honesty is bad for business’
The pharmaceutical industry has spoken out against introducing transparency when conducting clinical trials. The European Federation of Pharmaceutical Industries and Associations (EFPIA) have argued that the process must remain secretive in order to boost competition and increase their bottom line. Director of the EFPIA, Richard Bergstrom made the arguments after the organisation was pressured into publishing new ethical commitments relating[Read More…]
Follow Us!